EULAR 2023  | congress Abstract PRESENTATION

Instructions for abstract presentations

In the permanent ambition to support the rheumatology community with the best available information and education, EULAR offers this year a hybrid congress experience. This will enable us to keep the spirit of the global rheumatology community alive and to address urgent questions with immediate relevance for patient care.

  • Your presentation will be made available simultaneously virtually and on-site during the congress to all online and physical participants and thereafter to those who were not able to follow it during the conference.

  • To be able to do this, EULAR is asking you to grant EULAR a licence to your presentation, including, slides, images, voice etc. (hereinafter the "Content").

Other Resources:

If an abstract has been accepted as oral or poster presentation, the delegate will need to purchase a ticket for the virtual congress. Otherwise, the abstract will not be shown.

If an abstract is selected for oral or poster presentation, the presenting author shall:
— As specified at submission, present in the assigned session. Details will be communicated to the author by mid-April 2022.
— Sign an agreement in representation of all the abstract authors, to grant EULAR the right to record the entire presentation (audio and slide) and subsequently use it for educational purposes (with or without a fee).
— If an abstract is accepted as a poster presentation, the presenting author will be requested to be available for discussion during the corresponding poster viewing session.
— For further information contact: